Gujarat Kidney And Super Speciality Limited (NSE:GKSL)

Market Cap	10.04B
Revenue (ttm)	820.13M +103.8%
Net Income	154.97M +64.6%
EPS	2.49 +34.9%
Shares Out	78.84M
PE Ratio	51.13
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	149,087
Open	127.00
Previous Close	127.04
Day's Range	126.50 - 128.40
52-Week Range	98.36 - 148.34
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About NSE:GKSL

Gujarat Kidney and Super Speciality Limited operates multi-specialty and super-specialty hospitals. It provides treatment for Oncology, Neurology, Gastroenterology, Urology, Nephrology, and Physiotherapy. It also offers Renal Surgery, Vascular Surgery, Gynecology and obstetrics, Robotic Surgery, Bariatric Surgery, Laparoscopic Surgery, Endocrine Surgery, Neurosurgery, and Joint Replacement services. Its facilities include intensive care unit, patient counselling, operation theatres, and dialysis center. Gujarat Kidney And Super Speciality Limit...

• Industry: Hospitals
• Founded: 2014
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: GKSL

Financial Performance

In fiscal year 2026, NSE:GKSL's revenue was 820.13 million, an increase of 103.80% compared to the previous year's 402.42 million. Earnings were 154.97 million, an increase of 64.63%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jul 31, 2026

Data Sources Report a data error